PTPRC and neoplasm: The proportion of CD45+ immune cells was higher in sNK-infused tumor-implanted BLT mice as compared to mice implanted with tumors alone, and the addition of IL-2 further increased the levels of CD45+ immune cells within the tumor cultures.